Product Images Pfizer-biontech Covid-19 Vaccine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Pfizer-biontech Covid-19 Vaccine NDC 59267-4331 by Pfizer Manufacturing Belgium Nv, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PRINCIPAL DISPLAY PANEL – Multiple Dose Vial Label - covid 01

PRINCIPAL DISPLAY PANEL – Multiple Dose Vial Label - covid 01

Pfizer-BioNTech COVID-19 Vaccine is a vaccine formulated for the years 2023 to 2024. It needs to be diluted before use and is intended for individuals between the ages of 6 months and less than 5 years. After dilution, it is administered in 3 doses of 0.3 mL each, intramuscularly, and does not contain any preservatives. It is authorized for emergency use. After dilution, it should be stored at temperatures between 2 to 10°C (35 to 77°F) and should be discarded after 12 hours. The provided dilution date and time is not readable and therefore not available.*

PRINCIPAL DISPLAY PANEL – 10 Multiple Dose Vial Carton - covid 02

PRINCIPAL DISPLAY PANEL – 10 Multiple Dose Vial Carton - covid 02

PRINCIPAL DISPLAY PANEL – 0.3 mL Single Dose Vial Label - covid 03

PRINCIPAL DISPLAY PANEL – 0.3 mL Single Dose Vial Label - covid 03

PRINCIPAL DISPLAY PANEL – 10 Single Dose Vial Carton - covid 04

PRINCIPAL DISPLAY PANEL – 10 Single Dose Vial Carton - covid 04

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.